Cambridge Innovation Capital
Cambridge Innovation Capital (“CIC”) appointed Cadarn Capital in September 2026 to provide distribution and investor relations services for Fund III.
Fund III is CIC’s latest early-stage venture fund focused on the Cambridge ecosystem, investing in deep tech and life sciences companies emerging from the University of Cambridge and the wider region. CIC is a European venture capital firm investing in life sciences and technology companies with an affiliation to Cambridge, targeting seed through Series A rounds and beyond to bridge the gap between academic research and commercialisation.
Founded by the University of Cambridge in 2013, CIC serves as a preferred investor for university spinouts and early-stage ventures, giving it privileged access to the research and innovation pipeline of one of Europe’s leading science and technology clusters. CIC currently has invested in more than 45 companies, supporting over 100 founders across its portfolio, making it one of the most active early-stage investors in the Cambridge ecosystem.
Fund Structures
Listed funds are investment vehicles traded on regulated exchanges, offering investors daily liquidity, transparent pricing, and ease of access. They are typically subject to exchange rules and ongoing disclosure requirements, making them suitable for a broad range of investors.
UCITS funds (Undertakings for Collective Investment in Transferable Securities) are a type of highly regulated investment fund in the European Union (EU) designed for retail investors.
Alternative investment funds provide access to assets such as private credit, infrastructure, or real assets, with limited or periodic liquidity. These funds are designed for longer-term strategies, offering diversification benefits beyond traditional listed markets.
